A gentle touch against coughs and colds: could manual therapy shorten respiratory illness?
NCT ID NCT06495021
First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time
Summary
This study tests whether adding lymphatic pump osteopathic manipulative therapy (OMT) to standard care helps older adults recover faster from respiratory illnesses like bronchitis, sinusitis, or pneumonia. Participants aged 65 to 100 with a new respiratory diagnosis will receive OMT—a series of manual pressures and movements aimed at stimulating fluid flow and immune response—alongside usual treatments. The trial compares symptom severity and illness duration against standard care alone, with surveys taken at diagnosis and five days later.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Lymphatic pump osteopathic manipulative therapy (OMT), a hands-on manual therapy technique
- What this could lead to
- If effective, adding this hands-on therapy to standard care could shorten respiratory illness duration and reduce symptom severity in older adults.
- What could go wrong
- This is a small, early-stage trial, and results may not apply broadly. The therapy is generally safe but may not be suitable for people with certain fractures or active cancer treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 68 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2024
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients being seen for respiratory illness symptoms at Geisinger 65-Forward Buckhorn, PA clinic for care. * Patients age of 65-100 * New diagnosis of upper respiratory illness, sinusitis, bronchitis, or pneumonia during outpatient visit. Exclusion Criteria: * Patients that have a healing fracture, including the spine, pelvis, shoulder, ribs, vertebrae, or extremities. * Patients actively receiving any type of cancer treatment * Patients with active or previously diagnosed liver disease.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bronchitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Geisinger 65-Forward, Buckhorn
RECRUITINGBloomsburg, Pennsylvania, 17815, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One dose to block the flu: baloxavir put to the test in households
- Can a digital assistant and quick tests stop unnecessary antibiotics for kids?
- Nasal swab could curb unnecessary antibiotics in pneumonia
- Can a simple seawater spray tame cold and sinus misery?
- AI-Powered patient education: a new way to prepare parents for home care?
- AI could outsmart bacteria: a smarter way to choose antibiotics?